Physician profile
Breeze Goodrich
NPI 1285848333
$2,068.80
in general payments reported to CMS, 2019-2025
33 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $89.10 · 2021: $200 · 2022: $327 · 2023: $441 · 2024: $370 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.38 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $258.77 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $184.75 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $149.96 | 2023-2025 | Myfembree, Gemtesa |
| Gynesonics, INC. | $128.01 | 2021 | |
| Abbvie INC. | $126.37 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $116.69 | 2019 | |
| Mayne Pharma Commercial LLC | $105.33 | 2023-2025 | |
| Myovant Sciences INC. | $94.77 | 2021-2022 | |
| Ethicon US, LLC | $79.69 | 2022-2023 | Stratafix, Dermabond Prineo |
| Axonics, INC. | $78.22 | 2024 | Axonics, Bulkamid |
| Mylan Pharmaceuticals INC. | $72.89 | 2019-2022 | |
| Becton, Dickinson and Company | $72.16 | 2023-2024 | Arista Ah Flexitip |
| Allergan, INC. | $65.69 | 2019-2020 | |
| Therapeuticsmd, INC. | $62.01 | 2019-2022 | |
| Organon LLC | $58.69 | 2023-2025 | Jada System, Nexplanon |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $55.18 | 2023-2025 | |
| Convatec INC. | $44.55 | 2020-2024 | |
| Lupin INC. | $39.48 | 2019-2020 | |
| Novo Nordisk INC | $34.93 | 2021-2023 | Wegovy |
| Agile Therapeutics, INC. | $31.38 | 2022 | |
| Sage Therapeutics, LLC | $31.33 | 2023-2024 | |
| Shield Therapeutics INC | $20.52 | 2024 | |
| Daiichi Sankyo INC. | $17.46 | 2023 | Injectafer |
| Medicem INC. | $17.24 | 2023 | |
| Exact Sciences Corporation | $17.06 | 2025 | Cologuard Collection Kit |
| Avanos Medical | $15.15 | 2021 | |
| Mission Pharmacal Company | $14.22 | 2019 | |
| Duchesnay USA Incorporated | $13.60 | 2019 | |
| Coopersurgical, INC. | $13.32 | 2022 | |
| Avion Pharmaceuticals | $13.25 | 2020 | |
| Pfizer INC. | $13.01 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $12.57 | 2019 | |
| Aspira Women'S Health INC | $10.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breeze Goodrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.